CISPLATINE VIATRIS 1 mg/1 ml
Sponsors
Centre Hospitalier Universitaire De Nimes, Hospices Civils De Lyon
Conditions
The patient has a histologically-confirmed (ureteroscopic biopsy) or cytologically(urine cytology)-confirmed diagnosis of high-grade urothelial carcinoma of the renal pelvis or ureter.neoplastic pleural effusion
Phase 2
Safety and Efficacy of Neoadjuvant immunotherapy with Durvalumab (MEDI 4736) in combination with neoadjuvant chemotherapy (Gemcitabin/Cisplatin or Gemcitabin/Carboplatin) in patients with operable, high-risk, localized urothelial carcinoma of the upper urinary tract. iNDUCT - GETUG V08
Not yet recruitingCTIS2024-516077-72-02
Target: 50Updated: 2024-11-28
PITALC. Pilot study on the effect of PITAC (Pressurized IntraThoracic Aerosol Chemotherapy) by videothoracoscopy in patients with malignant pleural effusion in the light of the results of a retrospective historical cohort treated with talc pleurodesis by videothoracoscopy
Not yet recruitingCTIS2025-523482-23-00
Target: 20Updated: 2026-07-16